+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Tie-2 Receptor Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Tie-2 Receptor Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ephrin (EPH) Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Ephrin (EPH) Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CD 40 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CD 40 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hedgehog Signaling Pathway Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Hedgehog Signaling Pathway Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vascular Endothelial Growth Factor A Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Endothelial Growth Factor A Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
mTORC-1 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

mTORC-1 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Enhancer Of Zeste Homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Enhancer Of Zeste Homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Caspases Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Caspases Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Beta-3 Receptors Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-3 Receptors Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CCR Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CCR Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
CD (Cluster Of Differentiation) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CD (Cluster Of Differentiation) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Human Papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Human Papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Insight, 2025 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Carcinoid Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Carcinoid Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Muscle Invasive Bladder Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Muscle Invasive Bladder Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Intrahepatic Cholangiocarcinoma (ICC) - Pipeline Insight, 2025 - Product Thumbnail Image

Intrahepatic Cholangiocarcinoma (ICC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Acute Myeloid Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Myeloid Leukemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more